The 8th cohort of the Brandeis Innovation NSF I-Corps program wrapped up this month with a demo day on April 13, 2022. I-Corps Demo Day marks the culmination of weeks of work exploring the commercial potential of research conducted at Brandeis.
This year marks the first time that students from Hampton University, an HBCU, participated in the Brandeis program. The collaboration between Brandeis and Hampton was designed to increase the pipeline of historically underrepresented undergraduates pursuing graduate STEM education. Each team worked on commercialization strategies for one of four promising technologies:
- Palm to Calm, a palm fruit extract that shows promise in the fight against Type 2 diabetes, as well as offering antioxidant benefits
- Cancer Fighters+, a new chemotherapy agent that may improve outcomes in breast, prostate, and other cancers
- NextZyme, a sustainable biotechnology company that upcycles single-use plastics into new plastic material with the use of a special enzyme to break down the plastics.
- TeamLift, an AI and blockchain-powered platform building the missing infrastructure for the skills economy through the first skills wallet
Overall, the cohort spent over 250 hours working on their projects, interviewed over 60 people, and connected with companies in over 12 cities across the globe to speak with potential customers.